Company overview
Basic information
Company name
Biosyncora, UAB
Company code
302604130
VAT code
LT100005989413
Registered address
Vilnius, Gelvonų g. 31-7, LT-07138
Registration date
2011-03-17
Company age: 15 y. 7 mo.
Contact information
Edit data
Phone
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Email
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Website
https://www.biosyncora.com
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Private Limited Liability Company
NACE activity
Landscape service activities
Ownership form
Private without foreign capital
UAB Biosyncora
Company code: 302604130
Address: Vilnius, Gelvonų g. 31-7, LT-07138
VAT code: LT100005989413
Description
This description was generated by artificial intelligence.
Biosyncora, UAB (company code 302604130) is an operational private limited liability company registered on 17 March 2011. It is classified as a private, domestically owned enterprise with Lithuanian natural and legal persons holding more than 50% of the authorised capital and no foreign investor capital. The company is managed by a CEO only and is described as a micro company operating in the national private non-financial sector. Its registered address is Gelvonu g. 31-7, Vilnius, Vilniaus m. sav., Vilniaus apskr. The company’s activity is EVRK O.81.30.00, Landscape service activities. Share capital is €2.9K. In the latest available financial year, 2024, revenue reached €518.9K, up from €434.3K in 2023, while net profit rose to €38.9K from €16.3K. Profit before tax was €47.9K and the profit margin was 7.5%. Total assets increased to €333.7K, with equity at €166.8K and liabilities at €197.0K. Staff averaged 5 employees so far in 2026, compared with 4 in 2025. The average monthly wage was €1,660.76 so far in 2026, after €1,705.20 in 2025.
Download a detailed company report
Make confident decisions with all the information about Biosyncora, UAB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.